Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for TENAPANOR HYDROCHLORIDE
- Effect of Tenapanor on the Metagenomics and Metabolomics of Patients With Irritable Bowel Syndrome With Constipation
- Tenapanor for the Treatment of Pediatric Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
- Study to Assess the Safety and Efficacy of Tenapanor for the Treatment of IBS-C
- Study to Evaluate the Use of Tenapanor as Core Therapy in the Treatment of Hyperphosphatemia
- A Long-Term Study to Evaluate the Ability of Tenapanor Alone or in Combination With Sevelamer to Treat to Goal Serum Phosphorus in Patients With End-Stage Kidney Disease on Dialysis
- A Phosphate Binder Switch Study of KHK7791 in Hyperphosphatemia Patients on HD
- Study to Evaluate the Efficacy of Tenapanor as Adjunctive Therapy to Phosphate Binder Therapy
- A Phase 3 Study of Tenapanor to Treat Hyperphosphatemia in ESRD Patients on Dialysis
- Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of RDX5791 in Healthy Volunteers
- Safety, Tolerability, and Pharmacodynamics of RDX5791 in Healthy Volunteers
- A Long-Term Safety Study of Tenapanor for the Treatment of IBS-C
- A 26-Week Study to Evaluate the Efficacy and Safety of Tenapanor in IBS-C
- An 8-Week Study to Evaluate Tenapanor in the Treatment of Hyperphosphatemia in End-Stage Renal Disease Patients on Hemodialysis (ESRD-HD)
- A 12-Week Study With a 4-Week Randomized Withdrawal Period to Evaluate the Efficacy and Safety of Tenapanor for the Treatment of IBS-C
- A Phase 1 Study to Examine the Effect of Renvela on the Pharmacodynamics of AZD1722
- A Phase 1 Study to Examine the Pharmacodynamics of Different AZD1722 Formulations
- Safety, Tolerability, Pharmacokinetics and Pharmacodynamic of AZD1722 in Healthy Male and Female Japanese Subjects
- Pharmacodynamic Study of AZD1722 in End-stage Renal Disease Patients on Hemodialysis
Clinical trials list
click for details